Financial HighlightsResearch FundingFunding Source * Fiscal Year ‘97 Fiscal Year ‘98VMES Budget $2,887,931 $2,984,133Federal Grants and Contracts 1,282,230 1,327,683State Grants and Contracts 109,770 142,650Private Grants and Contracts 2,104,767 2,904,553*Excluding carryover funds<strong>Georgia</strong> Livestock and Poultry: Inventories and Values aNumber on FarmsSpecies and/or Produced Production ValueCattle Beef 1,392,000 $497,220,000Dairy 98,000 355,680,000 bHogs 1,640,000 209,200,000Poultry Broilers 1,182,800,000 2,276,890,000Non-broilers 19,869,000 17,112,000Eggs 4,867,000,000 358,941,000Turkeys 175,000 2,591,000Horses and Ponies 251,000 125,500,000aBased in part on information published by the <strong>Georgia</strong> Agricultural Statistics Service, Athens, <strong>Georgia</strong>bIncludes value to dairy cattle and milk produced<strong>Georgia</strong> Farm Cash ReceiptsCrops and Farm Forest (43.8%)Poultry and Eggs (44.3%)Dairy Products (4.2%)Meat Products (6.9%)Other Livestock (0.8%)24
Research Contracts and GrantsAllen, S.W. Pharmacokinetics and efficacy <strong>of</strong> transdermalfentanyl patches in cats and their effect on serum cortisolconcentrations. American <strong>College</strong> <strong>of</strong> <strong>Veterinary</strong>Surgeons, $10,000.The use <strong>of</strong> Monocryl in feline ovariohysterectomy.Mallinckrodt <strong>Veterinary</strong>, Inc., $4,000.Barton, M.H. Evaluation <strong>of</strong> the effects <strong>of</strong> polymyxin b onex vivo endotoxemia in horses. American <strong>Veterinary</strong><strong>Medicine</strong> Foundation, $12,998.The effects <strong>of</strong> endotoxin on equine leukocyte receptorexpression. U.S. Department <strong>of</strong> Agriculture, $16,561.Bounous, D.I. Genetic resistance through cellular immunemechanisms during the early phase <strong>of</strong> Marek’s diseaseinfection. U.S. Poultry and Egg Association, $32,261.Brown, S.A. Choice <strong>of</strong> antihypertensive agents in cats.Morris Animal Foundation, $31,386.Obesity, systemic hypertension, and progressive renaldisease in dogs. Morris Animal Foundation, $25,673.Potential benefits <strong>of</strong> benazepril in cats with chronicrenal insufficiency. Novartis Animal Health, $12,022.Brown, T.P. Study <strong>of</strong> spiking mortality <strong>of</strong> turkeys. NorthCarolina State <strong>University</strong>, $64,310.Diagnostics for avian enteric coronavirus infections incommercial poultry. U.S. Department <strong>of</strong> Agriculture,$10,205.Budsberg, S.C. Comparison <strong>of</strong> perioperative analgesiceffects <strong>of</strong> meloxicam and butorphanol in dogs undergoingstabilization <strong>of</strong> the stifle for cranial cruciate rupture.Boehringer Ingelheim Animal Health, Inc.,$42,150.Role <strong>of</strong> n-3/n-6 fatty acids in the development <strong>of</strong>degenerative joint disease: A dog stifle model. Hill’sPet Nutrition, Inc., $16,500.The effects <strong>of</strong> carpr<strong>of</strong>en on the ground reaction forcesin a canine chronic stifle osteoarthritis model. Pfizer,Inc., $28,279.Crowell-Davis, S.L. Effect <strong>of</strong> litterbox location on normaland inappropriate elimination behavior in cats. The PetCare Trust, $8,758.Dickerson, H.W., Jr. Can a DNA vaccine induce cutaneousimmunity in fish? Cornell <strong>University</strong>, $20,065.Dreesen, D.W. Antibody response to Rab Avert in veterinarystudents. Chiron Behring GmbH & Co., $55,994.The evaluation <strong>of</strong> safety and immunogenicity <strong>of</strong> a newchromatographically purified rabies vaccine (CPRV) inhealthy adult volunteers. Connaught Laboratories, Inc.,$19,424.Edwards, G.L. Afferent mediation <strong>of</strong> Amylin action.Amylin Pharmaceuticals, $3,000.Effect <strong>of</strong> CLA Supplementation in Dogs. Hill’s PetNutrition, Inc., $70,000.Evans, D.L. Analysis <strong>of</strong> chicken lymphocytes respondingto Campylobacter extracts. U.S. Department <strong>of</strong>Agriculture, $10,000.Streptococcus intial infections in trout and tilapia. U.S.Department <strong>of</strong> Agriculture, $133,200.Fayrer-Hosken, R. Development <strong>of</strong> a natural injectablesterilant vaccine for dogs and cats and the elucidation<strong>of</strong> a synthetic sterilant vaccine for dogs and cats. SpaySafe LLC, $729,687.Immunocontraception in African elephant usingporcine zona pellucida vaccine. Humane Society <strong>of</strong> theUnited States, $28,990.Investigating potential for PZP immunosterilization <strong>of</strong>feral pigs. The Nature Conservancy, $7,500.Ferguson, D.C. Production <strong>of</strong> a highly sensitive caninethyrotropin immunoassay using bioluminescence.<strong>Georgia</strong> Institute <strong>of</strong> Technology, $46,000.Finco, D.R. Beneficial effects <strong>of</strong> an ultralow phosphorusdiet on dogs with induced chronic renal failure. TheIAMS Company, $28,966.Garcia, M. Development <strong>of</strong> polymerase chain reactiondiagnostic method capable <strong>of</strong> distinguishing amonginfectious laryngotracheitis strains. U.S. Department <strong>of</strong>Agriculture, $3,650.Hanson, W.L. Evaluation <strong>of</strong> potential antileishmanialdrugs in animal models. U.S. Army, $207,000.Harmon, B.G. Carrier state for toxin-producing bacteriain cattle. U.S. Department <strong>of</strong> Agriculture, $16,010.Hoenig, M.E. Development <strong>of</strong> a specific and sensitiveassay for feline insulin and proinsulin. Morris AnimalFoundation, $11,600.25
- Page 3 and 4: VM E S ‘98Veterinary Medical Expe
- Page 7 and 8: DNA VaccinesEver since Dr. Edward J
- Page 9 and 10: Differential Diagnosis of Infectiou
- Page 11 and 12: Hemolysin is one type of virulence
- Page 13 and 14: ism without the epv gene. The resul
- Page 15 and 16: Cattle and Other RuminantsCattle, s
- Page 17 and 18: The Use of in situ Hybridization to
- Page 19 and 20: Endotoxin Antagonists: Characterizi
- Page 21 and 22: WildlifeGeorgia’s wildlife habita
- Page 23 and 24: Companion AnimalsCompanion animals
- Page 25: esearch paid for by VMES funds wher
- Page 29 and 30: Administrators and AdvisorsThe Univ
- Page 31 and 32: Hullinger, Gordon A., DVM, PhD, Ass
- Page 33 and 34: Selected PublicationsAllen, S.W., C
- Page 35 and 36: Hay, W.P., Baskett, A., Abdy, M.J.:
- Page 37 and 38: Quist, C.F., Howerth, E.W., Bounous
Change language